Business
US Patent Granted for PTX-200 for Ovarian Cancer Treatment
US Patent Granted for PTX-200 for Ovarian Cancer Treatment
About this update from Prescient Therapeutics Limited
[{"type":"text","content":"Prescient Therapeutics Ltd has released a press release. View Attachment","length":255,"tagName":"div"}]